Idhifa: Now Approved/Available Website Aug 16, 2017Aug 30, 2017 Brand: Idhifa (enasidenib), Tablets Parent Company: Celgene Drug Type: Boxed Warning Drug Category: Oncology Campaign: now-approved, Now Available Targeting: HCPs, Patients Patient Website: http://www.idhifa.com/ HCP Website: http://www.idhifapro.com/ Patient Home HCP Home Mobile HCP Home HCP Efficacy HCP Access